AU2013901842A0 - Targeted delivery of drugs to the myometrium - Google Patents

Targeted delivery of drugs to the myometrium

Info

Publication number: AU2013901842A0
Authority: AU; Australia
Prior art keywords: myometrium; drugs; targeted delivery; targeted; delivery
Prior art date: 2013-05-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2013901842A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Newcastle Innovation Ltd

Original Assignee

Newcastle Innovation Ltd

Filing date

2013-05-23

Publication date

2013-06-06

2013-05-23 Application filed by Newcastle Innovation Ltd filed Critical Newcastle Innovation Ltd

2013-06-06 Publication of AU2013901842A0 publication Critical patent/AU2013901842A0/en

2014-05-23 Priority to EP14800670.3A priority Critical patent/EP2999461B1/en

2014-05-23 Priority to AU2014271207A priority patent/AU2014271207B2/en

2014-05-23 Priority to PCT/AU2014/050049 priority patent/WO2014186843A1/en

2014-05-23 Priority to US14/892,927 priority patent/US10350167B2/en

2019-06-07 Priority to US16/435,061 priority patent/US10952964B2/en

Status Abandoned legal-status Critical Current

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
EP14800670.3A EP2999461B1 (en)	2013-05-23	2014-05-23	Targeted delivery of drugs to the myometrium
AU2014271207A AU2014271207B2 (en)	2013-05-23	2014-05-23	Targeted delivery of drugs to the myometrium
PCT/AU2014/050049 WO2014186843A1 (en)	2013-05-23	2014-05-23	Targeted delivery of drugs to the myometrium
US14/892,927 US10350167B2 (en)	2013-05-23	2014-05-23	Targeted delivery of drugs to the myometrium via anti-oxytocin receptor antibodies
US16/435,061 US10952964B2 (en)	2013-05-23	2019-06-07	Targeted delivery of drugs to the myometrium via polypeptides that bind to the oxytocin receptor

Publications (1)

Publication Number	Publication Date
AU2013901842A0 true AU2013901842A0 (en)	2013-06-06

Family

ID=

Similar Documents

Publication	Publication Date	Title
EP4005604B8 (en)	2023-07-19	Delivery of drugs
EP3019081A4 (en)	2018-04-25	Acoustic based drug delivery monitor
EP3047666A4 (en)	2017-04-12	Delivery of targeted media content
ZA201507918B (en)	2017-04-26	Nasal administration
EP3074073A4 (en)	2017-09-06	Medicament device
EP2961471A4 (en)	2017-04-05	Transdermal drug delivery device
IL240846A0 (en)	2015-10-29	Drug combination
EP3082817A4 (en)	2017-06-21	Compositions for drug administration
EP2999461A4 (en)	2017-02-08	Targeted delivery of drugs to the myometrium
AU2014271207A1 (en)	2016-01-21	Targeted delivery of drugs to the myometrium
IL234363B (en)	2020-04-30	Pharmaceutical preparation containing an antivirally active dihydroquinazoline derivative
ZA201507576B (en)	2017-01-25	Pharmaceutical combination drug
AP2015008208A0 (en)	2015-01-31	Pharmaceutical administration forms comprising
IL245705B (en)	2021-05-31	Pharmaceutical dosage forms
EP3046556A4 (en)	2017-04-26	Combination drug therapy
GB201319437D0 (en)	2013-12-18	Delivery of drugs
EP3006033A4 (en)	2017-01-04	Anticancer drug
AU2013901842A0 (en)	2013-06-06	Targeted delivery of drugs to the myometrium
EP3072516A4 (en)	2017-06-07	Antidepressant combination drug
EP3052475A4 (en)	2017-05-03	Pharmaceutical use of 3-benzylsulfonylpropionitrile
GB201319595D0 (en)	2013-12-18	Combination of Analgesic drugs
GB201316468D0 (en)	2013-10-30	Combination of analgesic drugs
IL244316A0 (en)	2016-04-21	Novel drug formulation
HK1219666A1 (en)	2017-04-13	Stabilization of moisture-sensitive drugs
AU2013901119A0 (en)	2013-04-18	Nanoparticles for drug delivery